SMTL ID : 6bbv.1

Crystal Structure of JAK2 in complex with compound 25

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.80 Å

Oligo State

monomer

Ligands

1 x D7D: N-{cis-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl}propane-1-sulfonamide(Non-covalent)

D7D.1: 20 residues within 4Å: Chain A: L.21, G.22, K.23, G.24, G.27, V.29, A.46, K.48, V.77, M.95, E.96, Y.97, L.98, G.101, S.102, R.146, N.147, L.149, G.159, D.160 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:V.29, A:L.149, A:L.149 Hydrogen bonds: A:E.96, A:L.98, A:R.146, A:R.146 Water bridges: A:K.23, A:S.102

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Vazquez, M.L. et al., Identification of N-{cis-3-[Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl}propane-1-sulfonamide (PF-04965842): A Selective JAK1 Clinical Candidate for the Treatment of Autoimmune Diseases. J. Med. Chem. (2018)

Release Date

2018-01-17

Peptides

Tyrosine-protein kinase JAK2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase JAK2

Related Entries With Identical Sequence